Company Filing History:
9 out of 1,521 
3 out of 1,360 
2 out of 1,243 
Years Active: 1996-2022
Title: Yung-fu Chang: Innovator in Medical Research and Therapeutics
Introduction
Yung-fu Chang is a prominent inventor based in Ithaca, NY. With an impressive portfolio of 14 patents, Chang has made significant contributions to the field of medical research, particularly in developing methods for treating infections and their associated symptoms. His innovations highlight a commitment to enhancing healthcare and improving patient outcomes.
Latest Patents
Among his latest patents, Chang has developed a method of treating infection or its associated symptoms. This innovative approach involves administering a therapeutically effective amount of a HMGB1 inhibitor to individuals suffering from infections. Additionally, he has introduced a method to inhibit toxin-induced cytotoxic effects in colon cells by using the same HMGB1 inhibitor. Another noteworthy patent from Chang provides novel immunogenic proteins, LigA and LigB, aimed at advancing the development of effective vaccines, antibodies, and improved diagnostic methods and kits.
Career Highlights
Throughout his career, Yung-fu Chang has worked with esteemed institutions, including the Cornell Research Foundation Inc. and Cornell University. His work at these organizations has allowed him to explore groundbreaking research and development, resulting in valuable patented technologies that address significant medical challenges.
Collaborations
Chang has collaborated with notable coworkers, including Raghavan U M Palaniappan and Douglas K Struck. These partnerships have furthered his research efforts, fostering a collaborative environment that enhances innovation and the potential for new therapeutic strategies.
Conclusion
Yung-fu Chang's contributions to medical innovation are substantial, as evidenced by his 14 patents and ongoing research. His methods for treating infections and developing vaccines not only reflect his inventive spirit but also signify hope for advancements in healthcare. As he continues to build on his work, Chang is poised to remain an influential figure in the realm of medical research and therapeutics.